Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia

Blood

Volumn 83, Issue 8, 1994, Pages 2038-2044

  Bedi, Atul ^a   Zehnbauer, Barbara A ^a   Barber, James P ^a   Sharkis, Saul J ^a   Jones, Richard J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; FLOW CYTOMETRY; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL;

EID: 0028256425     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.8.2038.2038     Document Type: Article

References (42)

1. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
2. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
3. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
4. Ben-Neriah Y, Daley GQ, Mes-Masson A-M, Witte ON, Baltimore D: The chronic myelogenous leukemia - Specific P210 protein is the product of the bcr-abl hybrid gene. Science 233:212, 1986
5. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83:5306, 1986
6. Lepine J, Messner HA: Pluripotent hemopoietic progenitors (CFU-GEMM) in chronic myelogenous leukemia. Int J Cell Cloning 1:230, 1983
7. Strife A, Clarkson B: Biology of chronic myelogenous leukemia: Is discordant maturation the primary defect? Semin Hematol 25:1, 1988
8. Andreeff M: Cell kinetics of leukemia. Semin Hematol 23:300, 1986
9. Dormer P, Lau B, Wilmanns W: Kinetics of bone marrow cell production in human acute and chronic myeloid leukemias. Leuk Res 4:231, 1980
10. Holdrinet RSG, Pennings A, van Egmond J, Wessels JMC, Haanen C: DNA-flow cytometry of blood and bone marrow in chronic myelogenous leukemia. Acta Haematol 69:98, 1983
11. Stryckmans P, Debusscher L, Socquet M: Regulation of bone marrow myeloblast proliferation in chronic myeloid leukemia. Cancer Res 36:3034, 1976
12. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS: Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925, 1991
13. Gishizky ML, Witte ON: Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science 256:836, 1992
14. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76, 1990
15. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C: Macrophage phagocytosis of aging neutrophils in inflammation. J Clin Invest 83:865, 1989
16. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize preB cells. Nature 335:440, 1988
17. Palacios R, Steinmetz M: IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727, 1985
18. Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D: Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med 152:1036, 1980
19. bcr/abl protein. Proc Natl Acad Sci USA 85:9312, 1988
20. Hariharan IK, Adams JM, Cory S: bcr-abl oncogene renders myeloid cell line factor independent: Potential autocrine mechanisms in chronic myeloid leukemia. Oncogene Res 3:387, 1988
21. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012, 1992
22. Jones RJ, Wagner JE, Celano P, Zicha MS, Sharkis SJ: Separation of pluripotent hematopoietic stem cells from multipotent progenitors (CFU-S). Nature 347:188, 1990
23. Szczylik C, Skorski T, Nicolaides NC, Manzella L, Malaguarnera L, Venturellí D, Gewírtz AM, Calabretta B: Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 253:562, 1991
24. Jones RJ, Zuehlsdorf M, Rowley SD, Hilton J, Santos GW, Sensenbrenner LL, Colvin OM: Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation. Blood 70:1490, 1987
25. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795, 1992
26. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from nucleated cells. Nucleic Acids Res 16:1215, 1988
27. Zehnbauer BA, Small D, Brodeur GM, Seeger R, Vogelstein B: Characterization of N-myc amplification units in human neuroblastoma cells. Mol Cell Biol 8:522, 1988
28. Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ: BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 81:2898, 1993
29. Belyavsky A, Vinogradova T, Rajewsky K: PCR-based cDNA library construction: General cDNA libraries at the level of a few cells. Nucleic Acids Res 17:2919, 1989
30. Brenner CA, Tam AW, Nelson PA, Engleman EG, Suzuki N, Fry KE, Larrick JW: Message amplification phenotyping (MAP-Ping): A technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechnique 7:1096, 1989
31. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte O, McCormick FP: Diagnosis of chronic myelogenous and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85:5698, 1988
32. Schmitt RM, Bruyns E, Snodgrass HR: Hematopoietic development of embryonic stem cells in vitro: Cytokine and receptor gene expression. Genes Dev 5:728, 1991
33. Kogan SC, Doherty M, Gitschier J: An improved method for prenatal diagnosis of genetic disease by analysis of amplified DNA sequences. N Engl J Med 317:985, 1987
34. Collins MKL, Marvel J, Malde P, Lopez-Rivas A: Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 176:1043, 1992
35. Shtivelman E, Lifshitz B, Gale RP, Roe BA: Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277, 1986
36. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell 74:823, 1993
37. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602, 1990
38. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 65:1097, 1991
39. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
40. Strasser A, Harris AW, Cory S: bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
41. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
42. Brach MA, de Vos S, Gruss H-J, Herrmann F: Prolongation of survival of human polymorphonuclear neutrophils by granulocytemacrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920, 1992